Loreto Vidaur

Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

Paul Bastard, Adrian Gervais, Tom Le Voyer et al. · Science Immunology · 2021 · 600 citations · Full text

De-escalation therapy in ventilator-associated pneumonia*

Jordi Rello, Loreto Vidaur, Alberto Sandiumenge et al. · Critical Care Medicine · 2004 · 249 citations

The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

Jérémy Manry, Paul Bastard, Adrian Gervais et al. · Proceedings of the National Academy of Sciences · 2022 · 180 citations · Full text

Ifn Autoantibodies, Immunology, Age Dependent +16

Decrease in Mortality in Severe Community-Acquired Pneumococcal Pneumonia

Simone Gattarello, Bárbara Borgatta, Jordi Solé‐Violán et al. · CHEST Journal · 2014 · 90 citations

Clinical Microbiology, Clinical Epidemiology, Respiratory Infection +1

Early non-invasive ventilation treatment for severe influenza pneumonia

Joan Ramón Masclans, J. Almirall, Leonardo Lorente et al. · Clinical Microbiology and Infection · 2012 · 85 citations · Full text

Ventilation, Severe Influenza Pneumonia, Respiratory Infection +1